FDA gives nod to hemophilia kit

09/14/2004 | NYTimes.com

Wyeth Pharmaceuticals won approval for its needle-free kit that reconstitutes factor VIII, an important blood protein that helps form clots. The ReFactor Antihemophilic Factor R2 kit is intended to help patients get regular treatment more quickly and safely for the inherited blood disorder.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations